Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study from Karolinska ...

In this Science segment, we examine the European Medicines Agency's recent decision to recommend granting marketing ...

Melbourne researchers have cracked the code for an enzyme found in high levels in the brain that could be key to treating ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Cognito Therapeutics today announced early-stage cost-effectiveness data supporting its Spectris therapy for Alzheimer's ...

Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Longtime Lakewood Ranch resident Andrea Helme marches forward on her goal of raising funds for Alzheimer's research and care.